Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Omega-3 Fatty Acids on Methotrexate Induced Hepatotoxicity in Children With Acute Lymphoblastic Leukemia

NCT02373579 is registered in ClinicalTrials.gov with Nancy Samir Elbarbary as lead sponsor.

NCT NCT02373579
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02373579 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Omega-3 Fatty Acids on Methotrexate Induced Hepatotoxicity in Children With Acute Lymphoblastic Leukemia
Lead sponsor
Nancy Samir Elbarbary
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2012
Completion date
October 31, 2014
Enrollment
70 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia